Allied World Commits $4.3M to St. Baldrick’s
Allied World Assurance Company Holdings, Ltd has announced a $4.3 million, five-year commitment to the St. Baldrick’s Foundation to accelerate lifesaving childhood cancer research.
A spokesperson said, “This transformative investment will fund critical studies designed to improve the quality of life for children undergoing cancer treatment while supporting the next generation of pediatric cancer researchers.
“Through the newly named Allied World – St. Baldrick’s Survivorship and Supportive Care Research Grant Program, this commitment will reopen an important research funding category. The program will support studies aimed at improving the quality of life for children undergoing treatment, as well as for survivors dealing with the long-term effects of therapy. Additionally, it will fund eight early-career physician-scientists as they conduct innovative research to enhance treatments and outcomes for children with cancer.
“Allied World’s partnership with St. Baldrick’s spans over two decades. Since 2001, the company has maintained strong ties through significant donations and dedicated employee involvement, proudly participating in fundraising events and volunteer efforts across Bermuda and the United States.”
Lou Iglesias, President & CEO of Allied World, commented, “Allied World is committed to using our resources to make a meaningful difference in the lives of children and families facing cancer. This donation represents our dedication to advancing critical research that will improve treatment outcomes and quality of life for children.”
“We are incredibly grateful to Allied World for this historic $4.3 million commitment, which will fuel groundbreaking research and improve the lives of children facing cancer. Allied World is filling gaps in the national childhood cancer pipeline, while serving as a model for Corporate America. We are indebted to this visionary company,” said St. Baldrick’s Foundation CEO, Kathleen Ruddy.
